Stock FRESENIUS KABI ONCOLOGY LTD
Add to a list
To use this feature you must be a member
Log inSign up
Inactive Instrument

News Fresenius Kabi Oncology Ltd

Equities

INE575G01010

End-of-day quote NSE India S.E.
Other stock markets
- INR - Intraday chart for Fresenius Kabi Oncology Ltd
2016 AstraZeneca sells rights to anaesthetics for up to $770 million RE
2015 Fresenius SE KGaA : Kabi sells German oncology compounding business RE

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
AstraZeneca sells rights to anaesthetics for up to $770 million
RE
Fresenius SE KGaA : Kabi sells German oncology compounding business
RE
Fresenius Kabi Oncology Ltd : India revokes GSK cancer drug patent in latest Big Pharma blow
RE
Fresenius Kabi Oncology Ltd : India board revokes GSK patent on breast cancer drug Tykerb
RE
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. Stock
  4. News Fresenius Kabi Oncology Ltd